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ABSTRACT: 
 Objectives: To compare the effects of two types of information, prevention and response, 
presented in medication guides and on patients’ perception of medication risks/benefits. Methods: 
Participants (N=215) were recruited using Amazon Mechanical Turk. The study utilized a 2x2 factorial 
design. The medication guide used in this study informed participants on the use of a hypothetical 
DMARD named Xelba. There were four versions of the medication guide that included variations of 
response and prevention information to a common side effect of a DMARD: infection. Data were 
collected via the internet. Results: Providing prevention and response information on the side effect of 
infection with the use of a DMARD did not affect participants’ perception of the medication.  
Conclusions: We found no evidence that providing prevention and response information about risks of a 
medication affects participants’ perception of the medication. More research on this topic should be 
completed to determine how to better format medication guides. Using a larger sample size to increase 
the power of the study, focusing on risk and prevention strategies that are less well known to 
participants, and using methods more similar to real life communication of medication information may 
reveal larger effects. 
 
INTRODUCTION: 
When a prescription is dispensed, written medication information is usually provided. These 
resources are paper handouts that contain information meant to educate patients on the risks and safe 
use practices of the drug being dispensed. A major purpose of a medication guide is being able to 
provide enough information to the patient so that he/she can avoid serious adverse events related to 
drug use.1 This information also provides instructions on how to prevent these serious adverse effects 
associated with taking the medication, warn individuals about significant health risks that could affect 
one’s decision to take the medication, and the need for proper adherence. If a pharmacist or physician 
misses the opportunity to counsel patients on appropriate use of the drug, these materials can become 
a sole resource in conveying important information to the patients.2 
This written medication information also comes in the form of a medication guide, one of the few 
forms of patient information mandated by the FDA. Medication guides are not required to be 
distributed with every medication but are becoming an element of those medications that have a Risk 
Evaluation and Mitigation Strategy (REMS.) During a five year period from 2006-2011, there was an eight 
fold increase in the number of medications that required a medication guide under REMS. However, the 
assessment of the readability, suitability, and comprehensibility of these resources showed little 
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improvement during this time period.3 Many of the studies that have assessed medication guides 
suggest that patients have an overall limited understanding of drug risks although receiving the 
information. 1-5 These studies also propose that medication guides are too complex and difficult for 
patients to comprehend due to the insufficient utilization of risk communication strategies. 
However, one research study looked at the effectiveness of a medication guide in conveying safety 
information to patients and found that a high percentage (93%) of patients remembered receiving 
medication guides and 86% had read at least part or the entire medication guide.7 Those who reported 
reading the medication guide had a higher percentage of correct responses to questions about 
information regarding potential risks of the medication, signifying enhanced knowledge of the drug’s 
side effects derived from the medication guide. This indicates that medication guides may be a resource 
to patients in understanding the potential risks of their medications, but are only the results of one 
study. 
Findings such as these demonstrate that patients are receiving written medication information, but 
they also encourage a push in improving medication guides and seeking a solution in the most effective 
way for them to provide useful medication information. There is a need for more research on the way 
information is communicated to patients through medication guides and patients’ ability to comprehend 
this information. The usefulness of a medication guide depends on its ability to provide information to a 
patient that is helpful in understanding and managing their medication. The high demand for research in 
this area leads to this study.  
In the medication guide for Enbrel (etanercept), a DMARD used for active rheumatoid arthritis, risk 
of serious infection is emphasized as the first item mentioned under the header: “What is the most 
important information I should know?”  The medication guide also explains how Enbrel can cause 
serious infections, describes symptoms of an infection to watch out for, and informs the user of things 
to tell their doctor before starting Enbrel. However, in the six page medication guide, this information is 
not organized or easy to find because it is broken up by other information and not placed in a clearly 
logical sequence. It is important for medication guides to explain the risks of a medication, but also how 
to minimize these risks (prevention) and what do to if risks appear (response) in a clear format where 
information is easy to find. The specific aim of this project is to compare the effect of two types of 
information, prevention and response, and their effect on the patients’ perception of medication 
risks/benefits. 
We hypothesized that the addition of either prevention or response information would increase 
participant willingness to take the medication. We did not expect that the addition of both prevention 
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and response information would result in a multiplicative effect on participant willingness to take the 
medication, or an effect on any of the secondary outcomes.  
 
STUDY DESIGN & EXPERIMENTAL MATERIALS: 
This study utilized a 2x2 factorial design with participants randomized to view variations of a 
medication guide for a hypothetical medication based on Enbrel. The medication guide used in this 
study informed participants on the use of a hypothetical DMARD by the name of Xelba. There were four 
versions of the medication guide that included variations of information.  
The first section of every medication guide had information that could be found in the Enbrel 
medication guide. This information included what the medication is indicated for and how it works. It 
then explained that the most important information to know about Xelba is its risk for serious side 
effects, especially risk of infection. Also, all medication guides included what participants should tell 
their doctor before starting Xelba, including their vaccine schedule/history and if the participant is 
currently displaying “symptoms of infection.” Medication guides 2 and 4 additionally had prevention 
information. This section of the medication guide gave the participant tips on ways to prevent infections 
while taking Xelba. Medication guides 3 and 4 additionally had response information. This segment 
explained to participants the importance of monitoring for symptoms of an infection and contacting 
their doctor if any of these symptoms occur while taking the medication. By responding to these 
symptoms, participants can treat an infection early on and prevent it from getting worse. 
Figure 1 below demonstrates what information was in each of the four Xelba medication guides. 
Figures 1a-3a in the Appendix contain screenshots of the different parts of our hypothetical medication 
guide. 
 
 
 
 
 
 
 
 
 
Figure 1: Information Provided in each “Xelba” Medication Guide 
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DATA COLLECTION METHODS:  
This research study used Amazon Mechanical Turk to recruit participants to take a Qualtrics 
survey. Amazon Mechanical Turk is a crowdsourcing web service that coordinates the activities of 
individuals who need tasks performed and workers who are paid for performing the tasks. Each 
participant was assigned to read one of the four variations of the medication guides for Xelba and 
answered follow-up questions.  These questions included demographic questions and questions 
assessing willingness to take the medication, perception of the medication’s risks and benefits, and 
perception of the likelihood of developing a serious infection when taking Xelba. The study population 
was limited to people over the age of 45. Patients who had rheumatoid arthritis were excluded due to 
potential bias. The Qualtrics survey included a timer so that we could assess the amount of time 
participants spent reading the medication guide. The Qualtrics survey also had an attention check 
question early in the questionnaire to allow us to exclude bots. Based on power calculations, we 
estimated that a sample size of 64 per group would provide a power of 0.8 to detect group differences 
equivalent to a standard deviation of 0.5. Therefore, a sample size of 256 was necessary to adequately 
power the study.  
 
MEASURES: 
 The primary outcome was willingness of the participant to take the medication. This was 
assessed by asking individuals: “If you had rheumatoid arthritis and your doctor prescribed this 
medication for you, how likely is it that you would take it?” Responses were recorded on a 7-point scale 
that ranged from 0=Very unlikely to 6=Very likely. Participants were also asked to indicate the most 
important reason for their response. Options provided were: a) most of the adverse events are not very 
serious; b) any serious adverse events are preventable; c) prefer to avoid taking medications and will do 
something else; d) the risk for infection is too likely; e) the risk of infection is too serious; and f) other.  
 Five secondary outcome variables were assessed. First, we assessed participants’ perception of 
whether medication benefits outweigh the risks by asking whether the participant agreed or disagreed 
with the statement, “The potential benefits of taking this medication outweigh the potential risks.” 
Responses were recorded on a 7-point scale that ranged from 0=Strongly disagree to 6=Strongly Agree. 
Second, we assessed participants’ perception of the safety of the medication by asking: “How safe or 
dangerous is this medication?” Responses were recorded on a 7-point scale that ranged from 0=Very 
dangerous to 6=Very safe. Third, we assessed participants’ perception on the likelihood of the 
medication helping their rheumatoid arthritis by asking: “If you had rheumatoid arthritis and took this 
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medication, how likely is the medication to help you?” Fourth, we assessed participants’ perception on 
the likelihood of getting a serious infection by asking: “If you had rheumatoid arthritis and took this 
medication, how likely are you to get a serious infection.” Finally, we assessed participants’ perception 
on the likelihood of recommending the medication to someone else with rheumatoid arthritis by asking: 
“How likely are you to recommend this medication to somebody else with rheumatoid arthritis?” 
Responses to these last three questions were recorded on a 7-point scale that ranged from 0=Very 
unlikely to 6=Very likely. 
 The following socio-demographic characteristics were also assessed: age (in years), gender, race 
(White/Caucasian, Black/African American, Hispanic/Latino, Asian/Pacific Islander, Arab American, or 
other),  highest level of education (Grammar School, High School or equivalent, Associate’s Degree, 
Bachelor’s Degree, Master’s Degree, Doctoral Degree, or other), and self-identification as a health care 
professional (yes/no). Race was dichotomized as White/Nonwhite and education was dichotomized as 
University Graduate/Not University Graduate. Lastly, perceived personal health status was assessed on a 
5-point scale that ranged from 1=Poor to 5=Excellent. Participants were asked whether they were 
currently taking any regular prescription medications (yes/no) and whether they had ever had serious 
side effects from taking medication (yes/no).  
 
STASTICIAL ANALYSIS:  
 Results were analyzed using regression analysis. Regression analysis was used to assess the 
effect of the two experimental conditions on the primary and secondary outcome variables.  This 
analysis included two indicator variables, designating group assignment with respect to whether a 
participant received prevention information (0=no; 1 =yes) or response information (0=no; 1 =yes) and 
an interaction between these two variables. If either of the main effects on the interventions were 
statistically significant, t-tests were used to examine between group differences. If the interaction term 
was statistically significant, the sample was stratified based on whether or not they viewed response 
information. T-tests were performed to assess differences between those who did and did not view 
prevention information. For these tests, alpha was set at 0.05. All calculations were performed using 
SAS.  
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RESULTS: 
Data were collected from 321 participants, however only 303 passed the attention check 
question and were over the age of 45 years old. We also excluded 88 participants because they did not 
spend sufficient time reading the study materials, bringing the total sample size down to 215. The mean 
age of study participants (N=215) was 53.6 (SD=6.02). Most participants were female (71.16%), white 
(88.37%), and have received a form of a college degree (71.63%). The percentage of participants 
reporting being in excellent, very good, good, fair, and poor health were 6.05, 32.09, 43.26, 15.35, and 
3.26, respectively. About half (50.97%) of study participants were currently using a prescription 
medication and 38.60% reported having experienced a serious medication side-effect in the past.  All 
demographic information can be found in Tables 1a-9a in the Appendix. None of these variables differed 
significantly across the experimental conditions.  
 
Table 1: Means (SE) for Outcome Variable by Format of Information (N=215) 
Outcome Variable 
Prevention Info Response Info 
No (N=121) Yes (N=94) No (N=111) Yes (N=104) 
Likely to Take 
Medication (Q2) 
2.88 (1.73) 2.84 (1.86) 2.94 (1.86) 2.78 (1.70) 
Medication 
Benefits 
Outweigh Risks 
(Q4) 
2.79 (1.66) 2.96 (1.87) 2.83 (1.85) 2.89 (1.66) 
Medication Safe 
(Q5) 
2.64 (1.46) 2.63 (1.33) 2.58 (1.48) 2.69 (1.32) 
Medication Likely 
to Help (Q6) 
4.10 (1.12) 4.20 (1.03) 4.14 (1.05) 4.15 (1.12) 
Likely to Get 
Serious Infection 
(Q7) 
3.51 (1.23) 3.37 (1.38) 3.34 (1.37) 3.57 (1.20) 
Likely to 
Recommend 
Medication to 
Others (Q8) 
2.17 (1.65) 2.26 (1.69) 2.08 (1.65) 2.33 (1.68) 
 
 Results for both the primary and secondary outcomes are displayed in Table 1 above. 
Unfortunately, none of the results were statistically significant. Also, the interaction between prevention 
and response information was not statistically significant for any of the outcome variables examined. 
However, the interaction between the prevention and response information and its effect on the 
willingness to take the medication (Q2) did approach significance at a p value of 0.116. Figure 2 below 
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shows the interaction. This interaction suggests that participants were most likely to take the 
medication when provided with neither response nor prevention information or if provided with both 
response and prevention information compared to being provided with either response or prevention 
information alone.  
 
Figure 2:  Interaction between Response and Prevention Information on Willingness of Participant to 
Take the Medication (Q2)  
  
DISCUSSION:  
 Unfortunately, we did not obtain a large enough sample size to adequately power our study 
which could result in not having enough participants to show anything of statistical significance. 
Therefore, it is difficult to determine if our hypothesis of adding prevention and/or response 
information about the risk of a medication increases participant willingness to take the medication is, in 
fact, false. Replicating this study with a larger sample size could provide more power to the study and 
consequently different results.  
 The approach of statistical significance on the interaction between the prevention and response 
information and its effect on the willingness of the participant to take the medication warrants some 
discussion. This interaction could suggest that participants are more willing to take a medication when 
they are not provided with the extra prevention/response information on the risk of the medication in 
their medication guide. Also, this interaction could suggest that if you give a participant either only 
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prevention information or only response information, then they are less willing to take the medication 
than if receiving both forms of information. Therefore, participants may be more willing to take the 
medication when provided neither of the extra information, or if provided with both how to prevent and 
how to respond to the explained side effect. However, to reiterate, this is only a suggestion of a possible 
interaction and it would be interesting to see if this interaction would reach statistical significance if 
replicated with a larger sample size. 
 Also, the inability to reach statistical significance in this study could be because of the generally 
well-known perception of infection as a side effect to participants. Perhaps the information on how to 
prevent or how to respond to signs of infection are already common knowledge for participants. For 
example, we are taught at a young age how to prevent getting serious infections by practicing good 
hygiene, avoiding contact with sick people, getting enough sleep, etc. Also, we may already respond to 
signs of infection by contacting our doctor even without it being a side effect from a medication. 
Participants may already know that, by responding to these symptoms, they can treat an infection early 
on and prevent it from getting worse. Therefore, the results may be different on how prevention and 
response information affects participants’ risk of their medication if participants were presented 
information on a side effect with uncommon prevention and response information. For example, the 
study could be replicated using the side effect of suicidality when taking antidepressants or the 
development of thrush when using an inhaled corticosteroid.  
 Lastly, the methods of our study could be a limitation. This study used a convenience sample by 
recruiting participants with Amazon Mechanical Turk and collecting data using the Internet. Although we 
tried to limit potential bias by excluding participants less than 45 years old or with rheumatoid arthritis, 
the generalizability of this patient population is unknown. It is always possible that making our methods 
more similar to how medication guides are distributed and communicated in real life could strengthen 
the study and make a difference in the results.  
 In conclusion, we found no evidence that providing prevention and response information about 
risks of a medication affects participants’ perception of the medication. More research on this topic 
should be completed to determine how to better format medication guides. Using a larger sample size 
to increase the power of the study, focusing on risk and prevention strategies that are less well known 
to participants, and using methods more similar to real life communication of medication information 
may reveal larger effects. 
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APPENDIX:  
Figure 1a: Information Provided in Medication Guides 1, 2, 3 & 4 
 
Figure 2a: Prevention Information Provided in Medication Guides 2 &4 
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Figure 3a: Response Information Provided in Medication Guides 3 & 4 
 
Table 1a: Age 
Age 45 46 47 48 49 50 51 52 53 54 55 56 57 58 
Percent 6.35 3.70 6.88 6.88 4.76 5.82 5.29 5.82 6.35 7.41 5.82 5.82 3.70 1.59 
Age 59 60 61 62 63 64 65 66 67 68 69 70 71 72 
Percent 5.29 4.23 3.70 1.06 1.06 4.59 2.12 1.06 1.06 0.53 1.06 0 0.53 0.53 
 
 
Table 2a: Gender 
Gender Percentage 
Male (1) 28.84% 
Female (2) 71.16% 
 
Table 3a: Race 
Race Percentage 
White/Caucasian (1) 88.37% 
Black/African American (2) 5.58% 
Hispanic/Latino (3) 3.26% 
Asian/Pacific Islander (4) 0.93% 
Arab American (5) 0.47% 
Other (6) 1.40% 
 
Table 4a: Education 
Education Percentage 
Grammar School (1) 0% 
High School or equivalent (2) 28.37% 
Associate’s Degree (3) 18.14% 
Bachelor’s Degree (4) 30.70% 
Master’s Degree (5) 16.28% 
Doctoral Degree (6) 3.72% 
Other (7) 2.79% 
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Table 5a: Health Care Professional 
Health Care Professional Percentage 
Yes (1) 1.40% 
No (2) 98.60% 
 
 
Table 6a: Health Rating 
Health Rating Percentage 
Excellent (1) 6.05% 
Very Good (2) 32.09% 
Good (3) 43.26% 
Fair (4) 15.35% 
Poor (5) 3.26% 
 
Table 7a: Prescription Medication Use 
Currently taking regular prescription meds? Percentage 
Yes (1) 59.07% 
No (2) 40.93% 
 
Table 8a: Previous Side Effect from Medication 
Serious side effects from taking a med? Percentage 
Yes (1) 38.60% 
No (2) 61.40% 
 
Table 9a: Participants per Medication Guide 
Med Guide 1 65 
Med Guide 2 46 
Med Guide 3 56 
Med Guide 4 48 
 
